期刊
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
卷 13, 期 9, 页码 897-900出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/17425255.2017.1364362
关键词
Disproportionate human metabolites; FDA guidance; metabolite safety testing; safety coverage
资金
- Eli Lilly Co.
- U.S. Food and Drug Administration